Statin Use in Patients With Cancer
Statin-oncology agent DDIs are relatively common but rarely is statin use contraindicated. Frequency of statins use varies according to cancer type. These findings highlight the importance of individualized risk-benefit assessments that consider prognosis, cardiovascular risk, potential drug interactions, and patient preferences to guide statin use in cancer patients.
Authors
- Carlo S. Legasto
- Alan H. Baik (ORCID: https://orcid.org/0000-0001-8840-8825)
- Brian Schulte (ORCID: https://orcid.org/0000-0002-3364-9872)
- Emily Chou
- Alan Chin (ORCID: https://orcid.org/0009-0007-2429-4735)
Institutions
- University of California, San Francisco (US)
- University of California, Irvine Medical Center (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102259
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94